Full text is available at the source.
Abstract
Qualitative exit interviews revealed insights into treatment experiences of patients with type 2 diabetes and established cardiovascular disease.
- Patients provided detailed feedback on their experiences with long-term treatment using dulaglutide and tirzepatide.
- Insights focused on the benefits that patients found most meaningful during their treatment.
- The study highlights the subjective perspectives of individuals regarding their management of type 2 diabetes.
Simplified